Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington, shared a post on X:
“Indeed phenomenal broad impact by our friend Tom Powles including excellent presentation at ESMO25 evaluating the clinical utility of ctDNA in IO-naive patients with MIBC in adjuvant setting:
IMvigor011 validated hypothesis generated by IMvigor010.”
More posts from ESMO25.
